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Estrogen worsens incipient hypertriglyceridemic glomerular remains speculative. In humans, estrogen replacement
injury in the obese Zucker rat. therapy has been found to be a preventative measure
Background. The obese Zucker rat (OZR) is a model of for the development of atherosclerosis via its antioxidantglomerulosclerosis and renal failure in the setting of hyperlipid-
and cholesterol-lowering effects [1], but it also can induceemia, hyperinsulinemia, and obesity. Our prior work in OZRs
hypertriglyceridemia [2]. The consequences of its hyper-has shown that ovariectomy attenuates glomerulosclerosis,
while added estrogen worsens it. To investigate the mechanism triglyceridemic actions on renal disease remain uninvesti-
of estrogen’s effects on glomerular disease in this model, we gated, and animal models of hyperlipidemia and glomeru-
evaluated the effects of ovariectomy and estrogen supplemen-
lar injury are important in understanding this interaction.tation on seven-week peripubertal OZRs. At this time point,
We have recently reported that estrogen replacementrats exhibit no overt histologic glomerular disease, but are just
beginning to show elevated urinary albumin excretion. accelerates the glomerulosclerosis seen in the obese
Methods. Female OZRs fed ad libitum were ovariectomized Zucker rat (OZR), a model of hyperlipidemia, obesity,
at four weeks, with or without estrogen supplementation to and hyperinsulinemia that has been proposed as a modelraise estrogen levels to just below those of preoestral adults
of hyperlipidemic renal injury [3, 4]. In these rats, hyper-(mean 16.5 pg/mL). Sham-operated controls were included.
lipidemia appears by three to four weeks of age, followedResults. Ovariectomy normalized albuminuria, lowered to-
tal and very low-density lipoprotein triglycerides, and reduced by macrophage deposition (4 weeks), albuminuria (6 to
glomerular fibronectin expression. Estrogen supplementation 7 weeks), altered production of matrix proteins (6 to 12
worsened albuminuria and raised total/very low-density lipo-
weeks), glomerular sclerosis (24 weeks), and early deathprotein triglycerides and total cholesterol. Estrogen-supple-
from renal failure (48 weeks) [5]. Prior studies havemented rats exhibited enhanced glomerular deposition of apo
A-IV and apo B, increased glomerular expression of desmin shown that the glomerulosclerosis seen in OZR is both
and type IV collagen, and increased interstitial macrophage histologically and biochemically similar to that seen in
deposition. other rat models of focal segmental glomerulosclerosisConclusion. Estrogen may be permissive for the early devel-
(FSGS) [6].opment of renal disease in OZRs and may act by increasing
In our earlier study, ovariectomy markedly reducedtriglyceride-rich lipoproteins, which then bind to glomerular
cells and initiate or accelerate glomerulosclerosis. albuminuria and glomerular sclerosis, while estrogen
supplementation worsened both. The estrogen supple-
mentation also markedly increased plasma lipids, espe-
Hyperlipidemia is increasingly accepted as a significant cially triglycerides (TGs). Given these findings, we de-
progression factor for renal disease. Although sex hor- signed experiments to investigate the mechanism of
mones are known to affect lipid levels, the relationship estrogen’s effects on the earliest detectable stages of
between this interaction and the course of renal disease renal injury, at six to seven weeks. At this time, histologic
glomerulosclerosis was absent, and urinary albumin was
just beginning to rise. The rats were, however, hyperlip-Key words: progressive renal disease, estrogen replacement therapy,
hypertriglyceridemia, glomerulosclerosis. idemic. We sought to determine how estrogen manipula-
tion would affect serum lipoproteins and their deposition
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METHODS with estrogen-free plasma. Estrogen recovery was calcu-
lated using the recovery of b counts in the reconstitutedRats
samples. A 17b-estradiol–specific radioimmunoassay (Di-
Female OZRs were obtained from the University of
agnostics Systems Laboratories, Webster TX, USA) was
California, Davis, Clinical Nutrition Research Unit Ani-
performed on the reconstituted samples, and the results
mal Model Core at four weeks of age. They were housed
were adjusted by accounting for the recovery percentage.
individually in stainless steel cages with wire mesh floors
and had free access to a soy-based diet and water. This Renal histology
soy protein-based (20%) diet was previously shown to
Following exsanguination under anesthesia, rats were
minimize renal injury in rats [7]. Body weights were
infused via the abdominal aorta with phosphate-buffered
measured twice weekly. The rats were assigned to one saline (PBS; 0.1 mol/L, pH 7.4) containing 6% sucrose
of three experimental groups: sham operated, ovariecto- and 500 U heparin/L for a sufficient time to blanch the
mized (Ovx), or Ovx and then supplemented with estro- kidneys. A 0.05% glutaraldehyde/4% paraformaldehyde
gen (Ovx 1 E) by subcutaneous implant. Surgery was in PBS fixative was then perfused for one minute or until
performed at five weeks of age by dorsal approach. Ani- the kidneys became rigid. The fixative was removed by
mals were sacrificed at seven weeks, and the absence of reperfusion with the PBS/sucrose/heparin solution. Tis-
ovaries was confirmed. sue was then embedded in paraffin for light microscopy
and immunohistochemistry as described [9]. SectionsEstrogen treatment
were then stained by the periodic acid-Schiff technique.
17b-Estradiol (15.3 mg/24 h) was administered by sub- Glomeruli were scored by the method of Raij, Azar, and
cutaneous implant at five weeks of age using time-release Keane as previously reported [10]. Thirty to 40 glomeruli
pellets (Innovative Research of America, Sarasota, FL, were scored from each kidney for three parameters:
USA) [3]. Pellets were placed at the nape of the neck FSGS, mesangial matrix expansion (MME), and mesan-
subcutaneously. The sham group received a placebo pellet. gial cellularity (MC). Each glomerulus was scored semi-
quantitatively on a scale of 0 to 4 for each parameter,Urinary albumin excretion
depending on the percentage of the glomerulus involved.
Urine was collected for all animals over a 24-hour FSGS was scored positive when MME, adhesion forma-
period by placing rats in stainless steel metabolic cages tion, and capillary obliteration were present in the same
and using flasks containing three drops of 10% sodium segment of the glomerulus.
azide solution to inhibit bacterial proliferation. Water
and moistened food were available. Urinary albumin Immunohistochemical localization of apolipoproteins
excretion (UAE) was determined using electroimmu- and monocytic cells
nodiffusion using rabbit antirat albumin and purified rat Sections stained for apolipoproteins A-1 and A-4, B,
albumin as previously described [3]. Urine collection was and E are processed as described [11]. Frozen, unfixed
performed at seven weeks of age. tissue was sliced at 4 mm, dried on slides, and kept at
2208C until used. Slides were air dried and fixed for 10
Plasma lipids, insulin, and glucose minutes in acetone, rinsed in PBS, and incubated with the
At seven weeks of age, the animals were fasted over- primary antibody diluted in PBS with 1% bovine serum
night and anesthetized with sodium pentobarbital. Blood albumin (BSA) for one hour (polyclonal anti–apo-A1,
was collected from the abdominal aorta using an ethylene- A4, B, or E; provided by Dr. A. van Tol, Rotterdam,
diaminetetraacetic acid (EDTA)-coated syringe. Plasma The Netherlands). Slides were rinsed in PBS, and endog-
was obtained by centrifugation and stored at 2708C. enous peroxidase was blocked by treatment with 0.075%
Very low-density lipoprotein (VLDL) was isolated by H2O2 in PBS for 30 minutes. Following another rinse,
centrifugation [8]. Plasma triglyceride and cholesterol the secondary, peroxidase-linked antibody diluted in
were measured by enzymatic, colorimetric assays (Sigma PBS with 1% BSA and 2% normal rat serum was applied
Chemical Co., St. Louis, MO, USA). Glucose and immu- to the slides and incubated for 30 minutes. Slides were
noreactive insulin were determined by radioimmunoas- rinsed and then immersed in the peroxidase reaction
say as previously described [3]. solution consisting of 5% AEC stock (4 mg 3-amino-9-
ethyl-carbazole per mL dimethylformamide) and 0.1%
Estrogen levels H2O2 (30%) in 0.1 mol/L sodium acetate buffer (pH 5.0).
A tritiated estrogen tracer was added to 0.5 mL Slides were then rinsed and counterstained with Meyer’s
plasma, which was then extracted with diethyl ether. Haematoxilin and mounted. Total glomerular lipid depo-
The ether fraction was isolated by immersion in dry ice- sition was assessed by Oil Red O staining [12]. Thirty to
cooled ethyl alcohol to freeze the aqueous phase. The 50 glomeruli per sample were scored on a scale of 0
(no staining) to 4 (strong staining throughout all of theether phase was then decanted, dried, and reconstituted
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glomerular visceral epithelium and mesangium of all glo- RESULTS
meruli). Female OZRs were ovariectomized or subjected to
Frozen sections were stained for monocytes/macro- sham surgery at four weeks of age; some Ovx rats were
phages using anti-ED1 (Serotec, Oxford, UK) as pre- also given estrogen by subcutaneous pellets. Supple-
viously described [13]. mented rats with estrogen levels exceeding the reported
adult OZR preoestral physiologic range of 27 to 68Reverse transcription-polymerase chain reaction of
pg/mL [15] were excluded from analysis to avoid possibleisolated glomeruli
complications of supra-pharmacologic estrogen levels.
Glomeruli were isolated by sieving followed by micro- Table 2 shows the characteristics of these rats. Estrogen
scopic dissection to exclude tubular contamination. Total treated rats ate less and had lower body weights. Estro-
RNA was isolated from 100 glomeruli by the method of gen levels were lowest in Ovx rats and highest in the
Chomczynski and Sacchi [14]. For reverse transcription estrogen-supplemented group. All estrogen-supplemen-
(RT), glomerular RNA was treated with 1.5 U DNAse I ted rats had estrogen levels below those reported in adult
(GIBCO, Grand Island, NY, USA). The RT reaction OZRs.
consisted of 3 mg of RNA, 1.5 U of RNAse-free DNAse I Because the appearance of albuminuria is a sensitive
(GIBCO), 5 mmol/L MgCl2, 2 U RNAse inhibitor early marker of glomerular disease, we chose to measure
(GIBCO), 2.5 mmol/L oligo(dT)16, and 15 mL diethyl it in these rats at six to seven weeks, when overt histologic
pyrocarbonate-treated water. This reaction was per- FSGS is not present. Figure 1 shows the amount of UAE
formed in an MJ Research ThermaCycler and was incu- in seven-week-old OZRs, either sham operated, Ovx, or
bated for 30 minutes at 378C, heated to 758C for 5 minutes Ovx 1 E. Normal levels in a lean rat are under 1 mg/day
to inactivate the DNAse, and then cooled at 48C. One- [16]. The control obese animals demonstrate abnormal
half microliter of 50 U/mL murine leukemia virus (MuLV) albuminuria (2.3 6 1.7 mg/24 h), which was normalized
reverse transcriptase (GIBCO) was added to each tube. by ovariectomy (0.45 6 0.06). Estrogen-treated rats de-
The reverse transcriptase reaction was run for 30 minutes
veloped severe albuminuria of up to 200 times normal
at 428C, followed by a 5-minute deactivation at 908C, and
(mean 97.3 6 23.7 mg/24 h). In similar studies usingthen cooled at 48C. For the polymerase chain reaction
control lean Zucker rats, no rats exceeded normal UAE(PCR), 2 mL of each reaction were added to 23 mL of
at 5 or 10 weeks (data not shown).PCR reaction mixture, which consisted of 25 pmol each
Given our previous data showing elevated TGs in 20-of forward and reverse primers, 2 mmol/L MgCl, 20
week OZRs treated with estrogen [3], we investigatedmmol/L dNTP, 25 mmol/L PCR buffer, 17 mL diethyl
hyperlipidemia at the onset of albuminuria. VLDL rep-pyrocarbonate-treated water, and 1 U DNA Taq Poly-
resents the predominant form of lipoprotein in themerase (GIBCO). The initial denaturation step ran for
Zucker rat [17]. Figure 2 shows total and VLDL TGsthree minutes at 948C, followed by 948C for one minute,
and total cholesterol from the same young animals as658C for two minutes, and then 758C for three minutes
shown in Figure 1 (VLDL cholesterols were largely un-for 35 to 40 cycles. This was followed by an extension
detectable). Quantitatively, VLDL TGs were the moststep at 728C for 10 minutes. Ten microliters of each
important lipoprotein measured. Ovariectomy loweredreaction was then mixed with DNA loading buffer and
total and VLDL TG levels, whereas estrogen replace-run on a 1.2% agarose gel and visualized by ethidium
ment markedly raised them (total TG: sham 298.3 6bromide staining. The primers used are listed in Table 1.
24.5, Ovx 172.9 6 12.4, and Ovx 1 E 544.0 6 61.6 mg/dL;Because quantitative RT-PCR with competitive prim-
VLDL TG: sham 191.9 6 16.2, Ovx 114.2 6 11.4, anders was not used in these studies, we only considered a
Ovx 1 E 420.8 6 52.2 mg/dL). In contrast, both ovariec-result to be positive if clear gene expression was demon-
tomy and Ovx with added estrogen increased serum cho-strated on repeated trials with absent expression seen in
lesterol (sham 84.2 6 3.7, Ovx 103.7 6 3.4, Ovx 1 Eother groups.
174.6 6 14.2 mg/dL). Regression analysis of UAE against
Statistical analysis lipid levels showed a strong correlation between UAE
and VLDL TGs (r 2 5 0.558, P , 0.0001; Fig. 3) andData were analyzed using GraphPad Prism version 2.01
between UAE and total TG (r 2 5 0.509, P , 0.0001).(San Diego, CA, USA). Data are presented as mean 6
The relationship with total cholesterol (r 2 5 0.441, P ,SEM. Data were first analyzed for normal distribution.
0.0001) was not as strong. Notably, the correlation be-They were then analyzed for differences using one-way
tween UAE and estrogen levels was much weaker thananalysis of variance (ANOVA), with a post hoc analysis
with the serum TG levels (r 2 5 0.351, P , 0.0001). Theusing a Tukey test for multiple comparisons. UAEs and
increased UAE could not be attributed to elevations inestrogen levels were transformed logarithmically prior
insulin or in glucose levels, as shown in Table 2.to this analysis to normalize results. Differences were
considered statistically significant at P , 0.05. The estrogen-associated increases in albuminuria and
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Table 1. List of primers used in this study
Type Primer
Glomerular protein primers
Heparan sulfate proteoglycan 59 GCGGAGTATGTCATTGGCAGTGTG39
59 AGGCGTCATCTGGGCACCACATCA39
Collagen IV-a1 59 CTCTGGGGACAACATCCG 39
59 TCTTCTCATGCACACTTGGC 39




Fibronectin 59 CTCCTGTGGTCATTGATGCCTCCA 39
59 GGTATGGTCTTGGCCTAAGCCTGA 39
Collagenase 72 kD 59 CCACGCTGCGGCAACCCAGATGTGGCCAAC 39
59 GTGGCAGCCCACGAGTTTGGCCACGCC 39
Collagenase 92 kD 59 ACCGCTATGGTTACACTCGG 39
59 GCAGGCAGAGTAGGAGTG 39
Cytokine primers
Interleukin (IL)-1a 59 AGCAACATCAAACAAAGGGAAG 39
59 GCAATTAACAGCTCTGGGAAAG 39




IL-6 59 CCTTCTCCACAAGCGCCTTCGGTC 39
59 GCCTGCAGCTTCGTCAGCAGGCTG 39
Tumor necrosis factor-a 59 CTCAGATCATCTTCTCAAAACTCG 39
59 TGTCCCTTGAAGAGAACCTG 39
Table 2. Biochemical characteristics of rats
Sham Ovari- Ovx 1
operated ectomized estrogen
Body wt g 21663 22664 19263ab
Estrogen level pg/mL 4.0961.42 0.6060.13a 16.4962.61ab
Insulin level pm/mL 12066257 965673 15486166
Glucose mg/dL 23865 266615 21363b
aP , 0.05 vs. sham operated
bP , 0.05 vs. ovariectomized
Fig. 2. Total and very low density lipoprotein (VLDL) lipids in seven-
week OZRs (N 5 20 to 30 per group). Symbols are: ( ) sham; (h)
Ovx; (j) Ovx 1 E; *P , 0.05 vs. sham; 1P , 0.05 vs. Ovx. Definitions
are in the legend to Figure 1.
glomerular staining, but no differences were seen in apo
E and apo A-I. Although there were no statistically sig-
nificant differences seen in Ovx animals versus control,
Fig. 1. Urinary albumin excretion in seven-week obese Zucker rats it is notable that Ovx animals were the only group to
(OZRs). Abbreviations are: sham, sham operated; Ovx, ovariectomized;
show nondetectable levels of glomerular apo E, A-I, andOvx 1 E, ovariectomized with estrogen replacement (N 5 20 to 30 per
group). A-IV. Total glomerular lipid deposition, as measured by
Oil Red O staining, was not detected in any group (data
not shown). No notable interstitial apolipoprotein stain-
ing was detected in any group. However, peritubularserum lipids were also associated with changes in glomer-
Apo A-IV was noted in most rats, independent of estro-ular apolipoprotein (apo) deposition, as demonstrated
gen status or amount of glomerular deposition (Fig. 5 c,by immunostaining shown and tabulated in Figure 4 and
5. Estrogen significantly increased apo B and apo A-IV d, arrows).
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Fig. 4. Apolipoprotein scoring in seven-week OZRs. Scoring repre-Fig. 3. Linear regression of VLDL triglycerides (TG) versus log (uri-
sents mean of 30 to 50 glomeruli per rat with five to six per group.nary albumin excretion, UAE) in seven-week OZRs (r 2 5 0.604, P ,
Symbols are: ( ) sham; (h) Ovx; (j) Ovx 1 E; *P , 0.05 vs. sham;0.0001).
1P , 0.05 vs. Ovx. Abbreviation ND is not detected.
Focal segmental glomerulosclerosis is associated with DISCUSSION
early alterations in glomerular cellular proteins involved
In this study, we report that estrogen manipulation ofin matrix expansion and basement membrane remodel-
young OZR affects cellular and clinical events at theing. To investigate this, we used RT-PCR of microdis-
onset of renal injury. Although previous studies havesected glomeruli to evaluate gene expression of selected
investigated the characteristics of renal disease in thematrix proteins. As shown in Figure 6, compared with
OZR, none have dealt with potential mechanisms ofsham-operated controls, ovariectomy reduced the ex-
disease onset. Previous work from our laboratories docu-pression of fibronectin, whereas estrogen treatment in-
mented gender specificity, with more severe glomerulo-
creased expression of desmin and type IV collagen. Es-
sclerosis found in female OZRs [5]. Subsequent work
trogen manipulation had no effect on the expression of showed that estrogen accelerated the development of
heparan sulfate proteoglycan, laminin, or the 72 or 92 glomerular damage in female OZRs at 21 weeks of age
kD collagenases (data not shown). These alterations in [3]. In these older rats, estrogen also raised serum lipids
glomerular gene expression came before any overt histo- from control levels, which in this model were already
logic changes in glomerular morphology were present, high [3]. Estrogen also increased albuminuria. The pres-
as the scorings of MC and MME were low in all groups ent study examines the effect of estrogen on glomerular
and was not affected by estrogen manipulation (data not damage in much younger rats at the onset of glomerular
shown). injury and shows that albuminuria can occur very early,
Lavaud et al have proposed that glomerular monocyte/ associated with a rise in serum lipids. Interestingly, ovari-
macrophage deposition, with consequent cytokine elabo- ectomy attenuated hypertriglyceridemia and glomerular
ration, is important in the development of renal disease disease, lowering urinary albumin excretion to below
in this model [6]. In these young rats, we investigated that of control animals.
both glomerular and interstitial macrophage deposition The effect of estrogen may be due to its hyperlipidemic
as well as cytokine expression. Shown in Figure 7 is a actions. Previous studies have shown conflicting effects
semiquantitative depiction of ED11 monocytes/macro- of estrogen administration on hyperlipidemia in OZRs,
phages in the renal glomerulus and interstitium. Despite but have not evaluated its effect on renal disease. Similar
evidence for incipient renal injury in control and estro- to our study, Wilson, Wilson, and Eaton showed in-
gen-treated groups, there was no evidence of increased creased serum TG with estrogen supplementation in Ovx
glomerular monocyte deposition. In contrast, the inter- OZR [18], but little effect on cholesterol. In contrast,
stitial monocyte/macrophage number was increased in Liao, Angelin, and Rudling found decreases in both TG
estrogen-treated rats. Two estrogen-treated rats exhib- and cholesterol [19]. It is unlikely that the hyperlipidemia
ited moderate interstitial fibrosis, but interstitial fibrosis was secondary to albuminuria alone. While it is possible
was absent in all other rats (data not shown). RT-PCR that the UAE of .100 mg/24 h seen in three estrogen
of microdissected glomeruli detected no intergroup dif- supplemented rats contributed to their hypertriglyceri-
ferences in expression of interleukin-1a (IL-1a), IL-1b, demia, this “nephrotic-range” albuminuria was not pres-
ent in a majority of rats in the high-estrogen group. InIL-2, IL-6, or tumor necrosis factor-a (data not shown).
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Fig. 5. Representative glomerular apolipo-
protein immunohistochemistry in seven-week
OZRs. Sections represent staining in estro-
gen-supplemented (a, c, and e) and sham-
operated (b, d, and f ) rats. Specific antibodies
against apo A-I (a and b), apo A-IV (c and
d), and apo B (e and f) were used. The arrow
denotes tubular apo A-IV staining (magnifi-
cation 340).
Fig. 6. Glomerular gene expression in seven-
week OZRs by RT-PCR. The results were
determined in duplicate (N 5 4 in each group).
the control and Ovx rats, none had UAE over 10 mg, albuminuria, glomerular deposition of apo A-IV and apo
B, and markedly elevated total and VLDL TGs. VLDLyet there were significant differences in lipid levels. It is
highly unlikely that differences in albuminuria of the and total TG levels correlated better with albuminuria
than did estrogen levels. Total cholesterol was modestlymagnitude seen in these rats can explain the reduction
in serum lipids seen in the Ovx animals. increased, and serum glucose and insulin levels were not
elevated. Added estrogen may therefore be acting viaRats given exogenous estrogen developed significant
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Fig. 7. Glomerular (A) and interstitial (B)
monocyte/macrophage deposition by ED1
staining. Means represent 20 scores from four
to five rats per group. Symbols are: ( ) sham;
(h) Ovx; (j) Ovx 1 E; *P , 0.05 vs. Ovx.
elevations in serum TG-rich lipoproteins and/or deposi- lipoprotein deposition may be important in the initiation
of disease in this model.tion of specific lipoproteins in the glomerulus. In con-
trast, ovariectomy in these prepubertal animals reduced Although these data suggest that estrogen manipula-
tion affected glomerular disease by changing lipid frac-albuminuria and reduced serum and VLDL TGs, al-
though the TG reductions were much less marked than tions, we cannot exclude a direct action of estrogen on
glomerular cells or an indirect action via an uninvesti-the elevations induced by added estrogen. Ovariectomy
did not change total cholesterol, insulin levels, or serum gated hormone, growth factor, or glomerular hemody-
namic effect. The latter is unlikely, as there is no evidenceglucose. While Ovx rats showed no statistically signifi-
cant changes in glomerular lipoprotein deposition, this that estrogen increases either systemic blood pressure
or transglomerular capillary pressure in strains of ratswas the only group to show nondetectable glomerular
apo A-I, A-IV, and E. not sensitive to salt. Additionally, at 9 to 13 weeks of
age, transglomerular capillary pressures do not differ inLipid deposition is an early marker of glomerular dis-
ease in these rats, and lowering lipids has previously been obese versus lean Zucker rats and are not changed by
pharmacologic reduction of serum lipids [26]. While glo-shown to reduce renal disease in OZR. Lipid-lowering
drugs, for example, reduce renal injury in OZRs in the merular cells contain estrogen receptors and bind and
proliferate in response to estrogen [27], it has not beenabsence of glomerular hemodynamic changes [4], pri-
marily from a reduction in serum cholesterol [20]. How- demonstrated that estrogen alone mediates the accelera-
tion of glomerular disease. The interaction of estrogenever, the hyperlipidemia of the OZR is characterized
by hypertriglyceridemia and VLDL elevations that are and lipids may be critical, as estrogen accelerates glomer-
ular disease in OZRs and other hyperlipidemic rat mod-quantitatively much more severe than hypercholesterol-
emia [17]. Michel et al reduced proteinuria and mesangial els [28].
We document several early estrogen-related changesexpansion in OZRs by the administration of acarbose,
which lowers intestinal absorption of carbohydrates and in the glomerular gene expression in OZRs. Ovariec-
tomy reduced glomerular fibronectin expression, whilelowered TGs but not cholesterol [21]. We have recently
achieved comparable attenuation of renal disease and estrogen treatment increased expression of desmin (pro-
duced mainly by podocytes in glomerular injury) [29]hypertriglyceridemia by preventing the hyperphagia
characteristic of these animals [22]. and type IV collagen. Increased desmin could reflect
podocyte damage from lipoprotein binding, with conse-This report demonstrates increased glomerular depo-
sition of apo B and apo A-IV in estrogen-treated rats, quent reduced glomerular basement membrane permse-
lectivity or simply a general mesangial phenotypic switchwithout significant changes in apo A-I, apo E, or total
lipid staining. Studies on the apolipoprotein composition (also manifested here by increased collagen IV) [30–32].
Other matrix proteins such as heparan sulfate proteogly-of hyperlipidemic OZR serum show varying patterns of
distribution and quantity, highly dependent on age and cans, laminin, and the 72 and 92 kD collagenases were
expressed in all groups and were not affected by estrogendietary modification [23]. Apo A and E can circulate in
either lipid-poor fractions or freely, unbound to lipids manipulation, perhaps reflecting the early stage of injury
in these rats. In the only other study evaluating glomeru-[24]. In contrast, apo B is totally insoluble in the absence
of lipids, so its appearance in the mesangium is most lar gene expression in young OZR, Lavaud et al noted
marked glomerular expression of collagen IV and fibro-likely as part of an intact lipoprotein. These data suggest
that there may be specific deposition of intact lipopro- nectin in 4- and 12-week male rats [6], but their data are
not comparable to ours, since time points and sex of theteins or free apolipoproteins in the glomeruli of estrogen-
treated rats. Since LDL and VLDL can induce pro- OZRs differed.
Our work does not support a significant role for infil-liferation in OZR mesangial cells [25], this glomerular
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